Back to Ovarian Cancer
NCT03823833
NCT03823833
Who may be able to join
Who might be able to join this trial:
- Women who have a non-cancerous ovarian cyst that is likely to come back, such as an endometrioma (chocolate cyst), dermoid cyst, or mucinous cyst
- Women who have had previous ovarian surgery and/or have a high risk of damage to their ovaries, such as having cysts on both ovaries or a cyst larger than 5 cm
- Women who have social insurance coverage
- Women who are able to understand and sign a consent form agreeing to take part in the study
Who may not be able to join:
- Women whose ovarian cysts are classified as "borderline" tumors (not fully benign but not fully cancerous — confirm with trial site)
- Women whose AMH levels (a hormone used to measure ovarian reserve) are too low to be measured by standard tests
- Women who have a personal history of blood clots in their veins or arteries (such as deep vein thrombosis or pulmonary embolism)
- Women who are currently pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Lille
Registry
clinicaltrials_gov
Start date
28 July 2021
Est. completion
4 April 2025
Where this trial is recruiting
🇫🇷 France
Primary endpoints
Number of mature oocytes eligible for cryopreservation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.